Your browser doesn't support javascript.
loading
Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
Heil, Jessica; Ganetsky, Valerie S; Salzman, Matthew S; Hunter, Krystal; Baston, Kaitlan E; Carroll, Gerard; Ketcham, Eric; Haroz, Rachel.
Afiliação
  • Heil J; Cooper University Health Care, Cooper Research Institute, Camden, New Jersey.
  • Ganetsky VS; Cooper University Health Care, Center for Healing, Division of Addiction Medicine, Camden, New Jersey.
  • Salzman MS; Cooper University Health Care, Center for Healing, Division of Addiction Medicine, Camden, New Jersey.
  • Hunter K; Cooper University Health Care, Center for Healing, Division of Addiction Medicine, Camden, New Jersey.
  • Baston KE; Cooper University Health Care, Department of Emergency Medicine, Division of Addiction Medicine and Medical Toxicology, Camden, New Jersey.
  • Carroll G; Cooper University Health Care, Cooper Research Institute, Camden, New Jersey.
  • Ketcham E; Cooper University Health Care, Center for Healing, Division of Addiction Medicine, Camden, New Jersey.
  • Haroz R; Cooper University Health Care, Department of Emergency Medicine, Division of Addiction Medicine and Medical Toxicology, Camden, New Jersey.
West J Emerg Med ; 23(3): 386-395, 2022 Apr 04.
Article em En | MEDLINE | ID: mdl-35679506
ABSTRACT

INTRODUCTION:

Like buprenorphine, methadone is a life-saving medication that can be initiated in the emergency department (ED) to treat patients with an opioid use disorder (OUD). The purpose of this study was to better understand the attitudes of emergency physicians (EP) on offering methadone compared to buprenorphine to patients with OUD in the ED.

METHODS:

We distributed a perception survey to emergency physicians through a national professional network.

RESULTS:

In this study, the response rate was 18.4% (N = 141), with nearly 70% of the EPs having ordered either buprenorphine or methadone. 75% of EPs strongly or somewhat agreed that buprenorphine was an appropriate treatment for opioid withdrawal and craving, while only 28% agreed that methadone was an appropriate treatment. The perceived barriers to using buprenorphine and methadone in the ED were similar.

CONCLUSION:

It is essential to create interventions for EPs to overcome stigma and barriers to methadone initiation in the ED for patients with opioid use disorder. Doing so will offer additional opportunities and pathways for initiation of multiple effective medications for OUD in the ED. Subsequent outpatient treatment linkage may lead to improved treatment retention and decreased morbidity and mortality from ongoing use.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Médicos / Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: West J Emerg Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Médicos / Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: West J Emerg Med Ano de publicação: 2022 Tipo de documento: Article